:: Home   :: Contact ICare   :: Site Map          
 | Home | About ICare | Research | CTR Library | Register | Contact ICare
Brain Cancer News
Brain Cancer Breakthrough News

Sept 24, 2008
ASTRO: Whole Brain Irradiation Linked to Cognitive Decline

  By Michael Smith, North American Correspondent, MedPage Today

BOSTON, Sept. 24 -- For cancer patients with up to three brain metastases, whole brain irradiation should be deferred as long as possible, a researcher said here.   <READ MORE>


Sept 4, 2008
Comprehensive Blueprints Revealed for Lethal Pancreatic, Brain Cancers

  By Johns Hopkins Kimmel Cancer Center (Press Release)

The complete genetic blueprint for lethal pancreatic cancer and brain cancer was deciphered by a team at the Johns Hopkins Kimmel Cancer Center.   <READ MORE>


Aug 25, 2008
ASCO: Bevacizumab (Avastin) Alone Shows Edge in Recurrent Glioblastoma 

  By John Gever, Staff Writer, MedPage Today

PHILADELPHIA, Aug. 25 -- Most hereditary neuroblastomas in children, as well as many sporadic cases, are attributable to mutations in a known cancer-associated gene, researchers here said.   <READ MORE>


May 30, 2008
ASCO: Bevacizumab (Avastin) Alone Shows Edge in Recurrent Glioblastoma 

  By Peggy Peck, Executive Editor, MedPage Today

CHICAGO, May 30 -- For refractory glioblastoma, second-line bevacizumab (Avastin) as monotherapy has been associated with a 28% response rate and an overall survival edge, albeit nonsignificant, over the agent plus irinotecan (Camptosar).  <READ MORE>


Jan 18, 2008
Implant Combination Prolongs Survival in Glioblastoma 

  By John Gever, Staff Writer, MedPage Today

CINCINNATI, Jan. 18 -- Survival in recurrent glioblastoma multiforme was extended without major toxicity by low-activity iodine-125 seeds and carmustine wafers (Gliadel) implanted simultaneously during brain surgery, researchers here said.  <READ MORE>


Jan 2, 2008
Negative Brain Mapping May Be a Positive for Glioma Surgery

  By Crystal Phend, Senior Writer, MedPage Today

SAN FRANCISCO, Jan. 2 -- When attempting to preserve language function during glioma resection, brain mapping that isolates areas without speech involvement may be more efficient than seeking areas with them.  <READ MORE>


Oct 30, 2007
ASTRO: Temozolomide (Temodar) Offers Long-Term Survival for Glioblastoma

  By Michael Smith, Senior Writer, MedPage Today

LOS ANGELES, Oct. 30 -- More glioblastoma patients are living longer when the oral alkylating agent temozolomide (Temodar) is combined with radiation therapy, found Swiss researchers.  <READ MORE>



:: 12 Element Approach ::
Explore and supplement your therapy with ICare's unique 12-Element approach to Patient Survival.

:: Breakthrough News ::
Breaking news on research for gentler, more effective therapies and information on lifesaving treatment options.

:: ICare Bulletin Board ::
View pertinent information regarding meetings and events pertaining to cancer patients. This is also a resource for contacting other patients about information and treatment options.

Copyright ⓒ ICare.  All rights reserved.